4//SEC Filing
Gangloff Scott A. 4
Accession 0000950170-25-088640
CIK 0001744659other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 9:08 PM ET
Size
5.4 KB
Accession
0000950170-25-088640
Insider Transaction Report
Form 4
Gangloff Scott A.
Chief Technology Officer
Transactions
- Sale
Common Stock
2025-06-18$54.84/sh−848$46,504→ 23,452 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. Such sales were automatic and not at the discretion of the Reporting Person.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $54.73 to $54.84, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Akero Therapeutics, Inc.
CIK 0001744659
Entity typeother
Related Parties
1- filerCIK 0001663253
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 9:08 PM ET
- Size
- 5.4 KB